Brazil's Anvisa bans ads for cannabis and mushroom products, notifies Medkaya

Brazil's health regulator Anvisa prohibited advertisements for cannabis and mushroom-based products that were circulating, and formally notified Medkaya Produtos e Serviços Farmacêuticos. The move signals stricter enforcement of formula manipulation rules, though the specific products and scope of the ban remain unclear. This could impact the emerging medicinal cannabis and psychedelics market in Brazil.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works